Gene · 8929
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Facemask in Congenital Central Hypoventilation Syndrome. | Respiration | 2023 | 38043520 | PubTator, text mining | PubMed |
| Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion. | Sci Immunol | 2023 | 38039376 | PubTator, text mining | PubMed |
| Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature. | Diagn Pathol | 2023 | 38031161 | PubTator, text mining | PubMed |
| Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation. | iScience | 2023 | 38026169 | PubTator, text mining | PubMed |
| Prdm12 represses the expression of the visceral neuron determinants Phox2a/b in developing somatosensory ganglia. | iScience | 2023 | 38025786 | PubTator, text mining | PubMed |
| Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets. | Aging (Albany NY) | 2023 | 38019470 | PubTator, text mining | PubMed |
| Genomic and transcriptomic characterization of pre-operative chemotherapy response in patients with osteosarcoma. | Sci Rep | 2023 | 38017005 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children. | BMC Cancer | 2023 | 38001404 | PubTator, text mining | PubMed |
| Exploration of the molecular mechanism of intercellular communication in paediatric neuroblastoma by single-cell sequencing. | Sci Rep | 2023 | 37990103 | PubTator, text mining | PubMed |
| Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model. | Sci Rep | 2023 | 37980388 | PubTator, text mining | PubMed |
| Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Int J Mol Sci | 2023 | 37958555 | PubTator, text mining | PubMed |
| Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938785 | PubTator, text mining | PubMed |
| Targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938771 | PubTator, text mining | PubMed |
| Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants. | Cold Spring Harb Mol Case Stud | 2023 | 37932047 | PubTator, text mining | PubMed |
| Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival. | Cancer Diagn Progn | 2023 | 37927813 | PubTator, text mining | PubMed |
| MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children. | Biosci Rep | 2023 | 37905791 | PubTator, text mining | PubMed |
| The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. | Noncoding RNA | 2023 | 37888204 | PubTator, text mining | PubMed |
| Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression. | Curr Oncol | 2023 | 37887559 | PubTator, text mining | PubMed |
| Minimal Residual Disease Detected by the 7NB-mRNAs ddPCR Assay Is Associated with Disease Progression in High-Risk Neuroblastoma Patients: A Prospective Multicenter Observational Study in Japan. | Biology (Basel) | 2023 | 37887060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8929/papers?page=9